Mendeleev Commun., 2011, 21, 146–148
Table 1 The regeneration of ionic catalysts 2, A and B in the reaction of
solvent for this reaction.‡,9(b) After reaction completion (TLC-
monitoring) MeOH was evaporated, the product was extracted
with Et2O, fresh portions of reactants 5a and 6a were added to
the recovered catalyst A or B, and the reaction was re-performed.
The activity and recoverability of supported catalyst A appeared
to be similar to that of hexafluorophosphate 2, but the enantio-
selectivity was somewhat lower (Table 1, entries 1 and 2). The
best results were achieved in the reactions catalyzed by the poly-
styrene system B containing moisture-resistant sulfated polymeric
anions, in which conversions and enantioselectivities remained
extremely high at least for four reaction cycles (Table 1, entry 3).
Moreover, the poorly soluble in organic phase catalyst B was
hardly ‘washed-out’ during the product extraction: the loss of
its mass over five cycles was less than 5% [for compound 2,
~20%9(b)]. However, after the fourth regeneration a gradual de-
activation of the system B was observed, which is characteristic
of all O-TMS-prolinol-type organocatalysts.
Next, we examined the catalytic properties of polyelectrolyte
B (10 mol%) in the asymmetric Michael reactions of trans-cin-
namaldehyde derivatives 5 with various carbon acids 6 (nitro-
methane 6a, dimethyl malonate 6b, and dibenzyl malonate 6c) in
96% aqueous MeOH. In all cases respective enantiomers of Michael
adducts [(S)- for 7a–e and (R)- for 7f–h] were obtained, yields
and ee values of the products were comparable with or even higher
than those attained with the use of PF6-containing catalyst 29(a),(b)
(Table 2). The synthesized compounds 7a, 7b, 7e, and 7f (or 7g) are
the intermediates for the preparation of chiral medicines Phenibut,9(b)
Baclofen,15(a),(b) Rolipram,15(c) and Paroxetin,16(a),(b) respectively.
Unlike other organocatalysts bearing ionic groups,9(a),(b) the catalyst
B remains solid (does not ‘liquify’) during the recovery and does
not contain moisture-sensitive and corrosion-dangerous fluorinated
anions, which would be undesirable in neoteric organocatalytic
technologies for the preparation of chiral medications.
trans-cinnamaldehyde 5a with nitromethane 6a.a
NO2
CHO
CHO
Catalyst (10 mol%)
+
MeNO2
96% aqeous MeOH,
20 °C, 24 h
5a
6a
7a
eec (%) (cycle)
Entry
1d
Catalyst
Conversionb (%) (cycle)
29(a)
100 (1); 100 (2); 100 (3);
89 (4); 70 (5)
95 (1); 94 (2); 94 (3);
94 (4); 94 (5)
2
3
A
B
100 (1); 100 (2); 100 (3);
95 (4); 74 (5)
100 (1); 100 (2); 100 (3);
100 (4); 80 (5)
92 (1); 92 (2); 92 (3);
92 (4); 92 (5)
95 (1); 96 (2); 95 (3);
95 (4); 94 (5)
aAll reactions were carried out using trans-cinnamaldehyde 5a (26 mg,
0.2 mmol) and nitromethane 6a (37 mg, 0.6 mmol) in 96% aqueous MeOH
(0.4 ml) in the presence of the indicated catalyst (10 mol% per monomer) at
room temperature for 24 h. bEstimated by 1H NMR. cEstimated by a chiral
HPLC. dAccording to ref. 9(b).
salts with the poly(4-styrenesulfonate) anions have been prepared
recently, however, O-TMS-a,a-diarylprolinol derivatives modified
with polyelectrolytes have not been reported so far.
The system A was prepared by mixing of hexafluorophos-
phate 2 with polyelectrolyte 3 in MeOH followed by the solvent
evaporation. The catalyst B was synthesized by the reaction
sequence including the silylation of the hydroxy group in com-
pound 1 and bromide-anion exchange with poly(sodium 4-styrene-
sulfonate) 4.†
We examined the systems A and B in the asymmetric Michael
reaction between trans-cinnamaldehyde 5a and nitromethane 6a
in 96% aqueous MeOH which is known to be the most efficient
†
NMR spectra were recorded in DMSO-d6 solutions on a BrukerAM300
Preparation of polyelectrolyte B. Chlorotrimethylsilane (326 mg, 384 ml,
3 mmol) was added dropwise to a solution of 3-{5-[(3R,5S)-5-(hydroxy-
phenylmethyl)pyrrolidin-3-yloxy]-5-oxopentyl}-1-methyl-1H-imidazol-
3-ium bromide 19(a) (772 mg, 1.5 mmol) and Et3N (455 mg, 606 ml, 4.5 mmol)
in CH2Cl2 (5 ml) at 4°C. The reaction mixture was stirred at room tem-
perature for 15 h. The solvent was removed in vacuo (15 Torr) and the
residue was dissolved in water (10 ml). To the obtained aqueous solution,
a solution of poly(sodium 4-styrenesulfonate) 4 (619 mg, 3 mmol per
monomer) in water (15 ml) was added dropwise with stirring. After 5 min,
the water phase was decanted, the remaining oil was dissolved in CH2Cl2
(50 ml), washed with distilled water (2×10 ml) and dried over anhydrous
Na2SO4. The solvent was evaporated in vacuo (15 Torr) and the residue
was dried under reduced pressure (2 Torr) at 35°C to afford 671 mg (65%)
of catalyst B as a reddish solid. According to NMR data, the polyelec-
trolyte B contained one imidazolium cation unit per one sulfated poly-
styrene anion unit. 1H NMR (25°C) d: –0.14 (s, 9H, SiMe3), 1.43 (m, 3H,
4-H, CH2CH2CH2COO), 1.74 [m, 3H, 4-H, CH2(CH2)2COO], 2.28 (m,
2H, CH2COO), 2.56 (m, 2H, ArCHCH2), 2.88 (m, 3H, 2-H, ArCHCH2),
3.70 (s, 3H, Me), 4.11 (m, 1H, NCH2), 4.33 (m, 1H, 5-H), 4.79 (m, 1H,
3-H), 7.13–7.38 (m, 12H, HPh, NCHCHN, HAr), 7.44 (m, 2H, HPh), 7.67
(m, 2H, HPh), 9.12 (s, 1H, NCHN). 13C NMR (25°C) d: 2.4, 20.8, 28.7,
32.8, 33.9, 35.5, 41.2, 48.2, 52.8, 54.9, 62.5, 74.7, 82.2, 122.1, 123.5, 126.6,
127.4, 127.6, 127.8, 136.6, 145.5, 146.1, 172.3. Found (%): C, 64.51; H, 6.74,
N, 6.25. Calc. for C37H47N3O6SSi (689.94) (%): C, 64.41; H, 6.87, N, 6.09.
spectrometer (300 MHz for 1H, 75 MHz for 13C, 282 MHz for 19F,
121 MHz for 31P). HPLC was performed on a Stayer chromatograph
equipped with an UV detector using a DAICEL Chiralpak® AD–H column.
Silica gel 0.035–0.070 (Acros) was used for a column chromatography.
4-Chloro- (5b), 4-nitro- (5c), 4-methoxy- (5d), 4-fluoro- (5f) (E)-cinnam-
aldehydes17 and 3-cyclopentyloxy-4-methoxy-(E)-cinnamaldehyde (5e)15(c)
were prepared according to the literature procedures. Poly(diallyldimethyl-
ammonium hexafluorophosphate) 3 was prepared from commercially
available poly(diallyldimethylammonium chloride) (Aldrich, average
MW 400000–500000, CAS26062-79-3).12 (E)-Cinnamaldehyde and poly-
(sodium 4-styrenesulfonate) 4 (Acros, average MW 70000, CAS25704-18-1)
were obtained from commercial sources and used without further puri-
fication.
Preparation of supported catalyst A. A mixture of poly(diallyl-
dimethylammonium hexafluorophosphate) 3 (38 mg, 0.14 mmol per
monomer), 3-(5-{(3R,5S)-5-[diphenyl(trimethylsilyloxy)methyl]pyrro-
lidin-3-yloxy}-5-oxopentyl)-1-methyl-1H-imidazol-3-ium hexafluoro-
phosphate 29(a) (46 mg, 0.07 mmol), and methanol (5 ml) was stirred at
room temperature for 30 min. The solvent was removed in vacuo (15 Torr)
and the residue was dried under reduced pressure (2 Torr) at 35°C to afford
84 mg (100%) of catalyst A. According to NMR data, the system A con-
tained one molecule of compound 2 per two monomer units of polyelec-
trolyte 3. 1H NMR (28°C) d: –0.11 (s, 9H, SiMe3), 1.26 [m, 14H, 4-H,
(CH2)2CH2COO, MeN+CH2CHCH2], 1.77 (m, 4H, MeN+CH2CHCH2),
2.30 (m, 2H, CH2COO), 2.87 (m, 2H, 2-H), 3.08 (s, 12H, MeN+CH2CHCH2),
3.72 (s, 8H, MeN+CH2CHCH2), 3.85 (s, 3H, Me), 4.16 (m, 1H, NCH2),
4.30 (m, 1H, 5-H), 4.80 (m, 1H, 3-H), 7.25 (m, 8H, HPh, NCHCHN), 7.44
(m, 2H, HPh), 7.69 (d, 2H, HPh, J 13.2 Hz), 9.06 (s, 1H, NCHN). 13C NMR
(28°C) d: 2.3, 20.8, 26.3–26.6 (polymer), 28.7, 32.7, 34.0, 35.7, 37.3–37.9
(polymer), 48.4, 51.4–54.8 (polymer), 52.7, 62.6, 69.2–69.6 (polymer),
74.6, 82.2, 122.2, 123.6, 126.5, 126.7, 127.4, 127.7, 127.8, 136.5, 145.4,
147.0, 172.3. 19F NMR (28°C) d: –70.8 (d, J 710 Hz). 31P NMR (28°C)
d: –143.3 (hept., J 710 Hz). Found (%): C, 45.59; H, 6.00; N, 5.63. Calc.
for C45H72F18N5O3P3Si (1194.06) (%): C, 45.26; H, 6.08, N, 5.87.
‡
Michael reaction and recycling procedure. A mixture of a,b-enal 5,
CH-acid 6, catalyst B (10 mol% per monomer), and 96% aqueous MeOH
was stirred for the indicated time at the indicated temperature (Table 2).
The solvent was evaporated under reduced pressure (15 Torr) and the
Michael adduct was extracted with Et2O (2×1 ml). The combined organic
extracts were concentrated in vacuo and purified by column chromato-
graphy using a mixture EtOAc/n-hexane (1:5–1:2) as an eluent. If appro-
priate, the catalyst that remained after the extraction of the product with
Et2O was reused by adding fresh portions of the reagents and the solvent.
All analytical data of the prepared compounds 7 were identical to the
reported ones.9(a),(b)
– 147 –